Navigation Links
Global Synthetic Biology Market 2014-2018
Date:7/28/2014

DUBLIN, July 28, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Synthetic Biology Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.

The analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.

The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Technology

08. Market Segmentation by Product

09. Market Segmentation by Applications

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series

Companies Mentioned:

  • Amyris Inc.
  • E. I. du Pont de Nemours and Co.
  • Thermo Fisher Scientific Inc.
  • Synthetic Genomics Inc.
  • Algenol Biofuels Inc.
  • ATG:biosynthetics GmbH
  • Bayer AG
  • Bioneer Corp.
  • Biosearch Technologies Inc.
  • Bristol-Myers Squibb Co.
  • CBC Comprehensive Biomarker Center GmbH
  • Cobalt Technologies
  • Evolva Holdings SA
  • Exxon Mobil Corp.
  • GeneWorks Pty Ltd.
  • Genomatica Inc.
  • Gevo Inc.
  • Ginkgo Bioworks
  • Green Biologics Ltd.
  • New England Biolabs Inc.
  • OriGene Technologies Inc.
  • REG Life Sciences LLC
  • Royal DSM
  • Synthorx Inc.

For more information visit http://www.researchandmarkets.com/research/dtxhfz/global_synthetic

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/12/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... June ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... partnership agreement with Shanghai Zillion has been signed. The agreement will grant exclusive ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, ... a national leader in opioid treatment, announced today they are partnering to combat ... Mytonomy recently deployed its virtual care platform at the Mayo Clinic to drive ...
(Date:5/31/2019)... (PRWEB) , ... May 29, 2019 , ... For many ... the toughest forms of cancer demand breakthrough therapies. Advances in immuno-oncology have led to ... patient’s own T cells with engineered T cell receptors known as “CARs”. The CAR ...
(Date:5/31/2019)... N.C. (PRWEB) , ... May 30, 2019 , ... ... is the first to demonstrate an efficient delivery system for the sustained release ... injuries. The platelet-rich plasma-based gel system was able to deliver CM into the ...
Breaking Biology Technology:
(Date:7/17/2019)... RAPID CITY, S.D. (PRWEB) , ... July 16, 2019 , ... ... begin to form, or to detect bone loss before it causes osteoporosis. For South ... reality. , “This is potentially a game-changer in terms of our ability to ...
(Date:7/9/2019)... (PRWEB) , ... July 08, 2019 , ... ... ruled in favor of Danisco’s ownership of the innovation behind two Danisco amylase ... an entitlement action could be based on prior art was without merit and ...
(Date:6/20/2019)... ... June 19, 2019 , ... ... the Infectious Diseases Society of America Foundation, and the possibly millions of dollars ... study infectious agents in AD, are a “welcome affirmation” of the need to ...
Breaking Biology News(10 mins):